On Jul 16, 2026, CNS reported earnings of 0.85 USD per share (EPS) for Q2 26, missing the estimate of 0.86 USD, resulting in a -1.57% surprise. Revenue reached 152.73 million, compared to an expected 150.94 million, with a 1.18% difference. The market reacted with a +4.42% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of 0.91 USD, with revenue projected to reach 159.34 million USD, implying an increase of 7.06% EPS, and increase of 4.33% in Revenue from the last quarter.